Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma
media
posted on 2020-05-18, 11:24 authored by Robin K. Kelley, Patrick Mollon, Jean-Frédéric Blanc, Bruno Daniele, Thomas Yau, Ann-Lii Cheng, Velichka Valcheva, Florence Marteau, Ines Guerra, Ghassan K. Abou-Alfa<p>The above digital features represent the opinions of the authors. These features consist of a graphical abstract, animated methods video, author-narrated video, plain language summary, slide deck, summary slide, and written scripts of the spoken content in both videos. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).<br></p>
<p>© The authors, CC-BY-NC 2020.</p>
<br>
<p> </p>
History
Related Materials
- 1.
- 2. DOI - Is supplement to Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma
